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Abstract

2

Negative pressure wound therapy (NPWT) is used clinically to promote tissue forma-
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tion and wound closure. In this study, a porcine wound model was used to further
investigate the mechanisms as to how NPWT modulates wound healing via utilization of a form of NPWT called the vacuum-assisted closure. To observe the effect of
NPWT more accurately, non-NPWT control wounds containing GranuFoam™ dressings, without vacuum exposure, were utilized. In situ histological analysis revealed
that NPWT enhanced plasma protein adsorption throughout the GranuFoam™,
resulting in increased cellular colonization and tissue ingrowth. Gram staining revealed that NPWT decreased bacterial dissemination to adjacent tissue with greater
bacterial localization within the GranuFoam™. Genomic analysis demonstrated the
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significant changes in gene expression across a number of genes between wounds
treated with non-NPWT and NPWT when compared against baseline tissue. However, minimal differences were noted between non-NPWT and NPWT wounds,
including no significant differences in expression of collagen, angiogenic, or key
inflammatory genes. Similarly, significant increases in immune cell populations were
observed from day 0 to day 9 for both non-NPWT and NPWT wounds, though no
differences were noted between non-NPWT and NPWT wounds. Furthermore, histological analysis demonstrated the presence of a foreign body response (FBR), with
giant cell formation and encapsulation of GranuFoam™ particles. The unique in situ
histological evaluation and genomic comparison of non-NPWT and NPWT wounds in
this pilot study provided a never-before-shown perspective, offering novel insights
into the physiological processes of NPWT and the potential role of a FBR in NPWT
clinical outcomes.

Abbreviations: FBR, foreign body response; GAG, glycosaminoglycans; H&E, hematoxylin & eosin; HPF, high powered field; MMP, matrix metalloprotease; NBF, neutral buffered formalin;
NPWT, negative pressure wound therapy; ROI, regions of interest; ROS, reactive oxygen species; VAC, vacuum-assisted closure.
Jacob G. Hodge and Ashley L. Pistorio are the co-first authors.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2021 The Authors. Wound Repair and Regeneration published by Wiley Periodicals LLC on behalf of The Wound Healing Society.
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I N T RO DU CT I O N

|

signalling events results in a transition from acute to chronic inflammation, granulation tissue deposition, neovascularization and a pheno-

The term, ‘wound healing’, is a very broad way to describe a highly

typic switch from M1 to M2 macrophages.16,24 Following failed

complex yet predictable set of cascading events that occur in the set-

attempts of ‘frustrated’ macrophages to phagocytose the foreign

ting of tissue damage that has resulted from loss of tissue structure

object, foreign body giant cells (FBGC) are formed, which are

and function.1,2 When our bodies incur a form of tissue damage

multinucleated giant cells derived from fused macrophages that aid in

resulting in either superficial, deep, or even structural damage, the

the fibrotic encapsulation and/or expulsion of the foreign object from

skin is often left traumatized and exposed. The subsequent series of

the body.16,24 Failure to expel the foreign object from the body results

systematic events impartially affect most types of wounds and tissue

in a sustained stimulus and chronic inflammation.

after an injury. Those defined events are haemostasis, which results in

To this day, there is yet to be a singular type of wound care modality

tissue exposure to blood proteins, platelet activation, clot formation

proven most effective for all wounds. However, occlusive or semi-

and provisional fibrin matrix formation.3 Next is inflammation, which is

occlusive dressings that create and maintain a moist environment are

a series of inflammatory signals that results in immune cell migration

considered the mainstay of wound care.14,15 A recent and innovative

4

into the wound site and removal of damaged debris and bacteria.

strategy for wound care is the vacuum-assisted closure (VAC) system.

This is followed by the proliferative phase, the stage of granulation tis-

The VAC system is a form of negative pressure wound therapy (NPWT),

sue formation that includes neovascularization, fibroblasts prolifera-

which has gained increasing interest since its inception in 1997.25,26 The

5,6

tion and wound contraction.

Fibroblasts become the key

VAC has shown clinical efficacy in a number of settings including surgical

contributor during this phase and begin dispersing throughout the

wounds and preparation of surgical wound sites for closure or grafting,

wound site to prepare the tissue for the final stage of remodelling,

traumatic wounds, skin grafting, complex ulcerative wounds (diabetic,

which occurs after wound closure from reepithelialization.7 Fibro-

pressure and venous stasis induced), and wounds involving exposed bone

blasts delicately perform the remodelling process through a synchro-

and orthopaedic implants.27–30 The VAC system consists of inserting an

nized balance of collagen deposition and simultaneous degradation

open-cell reticulated polyurethane-derived foam dressing into a wound,

via secreted enzymatic factors, such as matrix metalloproteases

called GranuFoam™, followed by sealing the wound site by applying a

(MMPs).8,9 The overall purpose of this cascade of events is returning

semi-permeable adhesive film over the wound and foam dressing. The

the tissue to a state of anatomical homeostasis and restoration of

VAC system is then attached to a subatmospheric pressure system, typ-

function.2 These four distinct stages are used to define our body's ini-

ically set at 125 mmHg for this material. The open-cell reticulated char-

tial response to tissue damage, also known as acute wound healing.

acteristic of the foam provides equal distribution of forces throughout

The complex and dynamic nature of wound healing often can result

the wound site and the ability for air and fluid to freely pass through

in perturbation of acute wound healing, leading to pathological wound

the foam.25,31 Application of subatmospheric pressure results in con-

9,10

healing.

Pathological wound healing can be thought of as a contin-

traction of the reticulated foam and a mechanical decrease in wound

uum of physiologic healing where an aberrant process leads to an imbal-

site volume, thus bringing the wound edges closer together. This is sim-

ance. One such imbalance can lead to excessive scar tissue formation

ilar to how sutures close surgical wounds or a compression bone plate

11,12

and fibrosis.

Conversely, with insufficient scar tissue formation there
11,13

is a deficit in healing which can result in ulcer formation.

bridges together two pieces of bone.32,33 Moreover, exposure of

Abnormally

wounds to the subatmospheric pressure VAC system has been claimed

healing wounds can become chronic and result in complicated, non-

to enhance blood flow, remove excess fluid, decrease bacterial load,

healing wounds accompanied by chronic inflammation.11,14 There are

promote cellular proliferation, stimulate granulation tissue formation

several systemic and local factors that can have a negative influence on

and expedite the overall wound healing process.25,26,31,34

wound healing leading to chronic inflammation and non-healing wounds,
including the presence of an infection or foreign body.15–17

A current hypothesized mechanism of how the VAC system
decreases bacterial load revolves around increased oxygenation from

Infection within a wound site triggers a proinflammatory response

augmented neovascularization within the wound.25,31 The increased

that prompts recruitment of neutrophils, production of reactive oxy-

circulation leads to improved neutrophil recruitment and the higher

gen species (ROS) and proteases, and subsequent tissue damage.18,19

abundance of oxygen provides means for neutrophil oxidative burst

Inability to resolve the infection can result in chronic inflammation

activity.35 However, the data surrounding this mechanism are not fully

and a sustained state of non-healing.20,21 The foreign body response

understood and requires further study.36,37 Clinically, bacterial burden

(FBR) is characterized by adsorption of plasma proteins onto a foreign

is of high interest to physicians due to the negative impacts it can

object, which serves as both a biological stimulus and an anchor point

have on proper wound healing.19 Although bacteria are known to

22,23

for inflammatory cells.

A subsequent series of inflammatory

adhere to plastic implants or other devices, they have not yet

3
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specifically been shown adhering or proliferating directly on

deposition and encapsulation of the foreign body.24 Moreover, plasma

GranuFoam™. Yet, blood and matrix proteins, such as fibrinogen and

protein-coated plastics have been shown to enhance the adhesion

vitronectin, are known to adsorb onto biomaterials upon implantation

and proliferation of bacteria.38,40,41 Thus, plasma protein adsorption

23,38

into the body.

Plasma protein adsorption results in modulation of

and tissue enmeshing together could provide seed points for bacteria

the inflammatory response and subsequent cellular colonization and

to adhere to and propagate within the GranuFoam™. Consequently, it

matrix deposition within the pores of the foam, known as

is possible that there is a higher bacterial presence than originally

‘enmeshing’.

thought, due to bacteria residing within the foam and the foam sur-

24,39

Therefore, the FBR can be thought of as a stimulus

for tissue enmeshing due to the promotion of fibrous matrix

face interacting with the wound environment.

F I G U R E 1 Surgical procedure overview. (A) Two arrays consisting of eight full-thickness wounds (1 cm3) each were made on the back of two
female Yucatan Miniature Pigs (n = 2) with a custom biopsy wound punch. The same dressing configurations were applied to both wound arrays.
NPWT was applied using the KCI/Acelity VAC Via™ unit to the wound array on the right side, but not to the wound array on the left side of the
animal. Dressings were changed, clinical images were taken and elliptical excisional explants were collected for tissue analysis of wounds at 0, 3,
6 and 9 days post-surgery. (B) Animals were allowed to acclimate to the facility 2 weeks prior to surgeries. (C) Five days prior to surgeries, animals
were fitted with custom protective jackets to house the vacuum pump and protect wound sites. (D) 1 cm3 full-thickness wounds were made with
a custom 3D-printed biopsy punch. (E) A 2  4 wound array was made on each flank of each animal. (F) Biopsied tissue was cleanly removed and
was preserved for histological and genetic analysis. (G) KCI/Acelity GranuFoam™ plugs (1 cm  1 cm  2 cm) were inserted into each wound.
(H) The perimeter of each wound array was protected by DuoDerm® dressings. (I) A TheraBond® 3D Antimicrobial dressing was placed around
the wound array with 1 cm2 openings pre-cut to enable GranuFoam™ plugs to protrude. (J) A large GranuFoam™ Bridge was placed over the
wound array to directly interface with the GranuFoam™ plugs. Afterward, a VAC semipermeable Tegaderm™-like drape was securely placed over
the wound array to make an airtight seal. A 1 cm2 hole was cut in the drape, and a vacuum port was attached. (K) Wound array under NPWT
results in GranuFoam™ compression. (L) Wound array without NPWT (foam is not compressed). (M) Wounds sutured closed after elliptical
excision of the wound with GranuFoam™ in situ for analysis
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In this pilot study, a porcine wound array was developed to estab-

thickness wounds that were approximately 1 cm long by 1 cm wide

lish a holistic and temporal perspective for the evolution of the wound

by 1 cm deep on both the left and right side of the animal's back for a

healing process and expand upon the original study performed by

total of 16 wounds on each animal. Biopsies were bisected and pre-

Morykwas and Argenta.25,26 A porcine model was used due to the

served as baseline tissue controls in neutral buffered formalin (NBF)

similarities between the wound healing processes of pigs and humans

or RNAlater™ (Sigma-Aldrich, St. Louis, MO) for downstream analysis.

(Figure 1). The mechanisms behind how the VAC system exerts its

The wounds were closed with 2-0 Prolene® sutures (Johnson and

effect on the wound healing process over time was assessed by con-

Johnson, New Brunswick, NJ) using an interrupted horizontal mattress

trolling for the effects of the GranuFoam™ dressing without subatmo-

suture technique with alternating directions for each closure. The four

spheric pressure. The impact of removal and reapplication of the foam

most posterior wounds were closed on day 0, post initial surgery.

dressing on wound healing was evaluated, in addition to how the VAC

A DuoDerm® dressing (ConvaTec, Bridgewater, NJ) was used to form

system may be mitigating bacterial load. We aimed to determine the

a perimeter around each wound array. All remaining open wounds

relationship between the foam dressing and bacterial burden in situ,

were plugged with a pre-cut GranuFoam™ dressing (1 cm long  1 cm

compared to the traditional method of ex vivo biopsy analysis of the

wide  2 cm deep) (Kinetic Concepts Inc. [KCI] an Acelity company,

wound bed without the dressing, which to our knowledge has never

San Antonio, TX). A TheraBond® 3D Antimicrobial System dressing

been investigated up to this point. We hypothesized that protein

(Argentum Medical LLC, Geneva, IL) with pre-cut windows was placed

adsorption and tissue enmeshing within the GranuFoam™ is providing

around each wound array enabling the GranuFoam™ plugs to protrude

potential seed points for bacteria to adhere to within the GranuFoam™

through. No systemic antibiotics were used. A GranuFoam™ pad was

dressing with increased protein adsorption and enmeshing due to

placed over each wound array so that all protruding GranuFoam™ plugs

exposure to subatmospheric pressure. Proliferating bacteria within the

interfaced directly with the GranuFoam™ pad. A Tegaderm™-like VAC

GranuFoam™ between dressing changes could be negatively augmenting

adhesive drape was placed over each wound array so that it completely

the wound environment. This pilot study provides a new perspective

covered the wound array and DuoDerm® dressing. A 2.5 cm hole was

to the mechanism of bacterial mitigation by the VAC system.

cut in the centre of each VAC drape, and a VAC port was attached.

Additionally, the non-NPWT control group paired with the in situ per-

A VAC VIA™ pump (KCI/Acelity) was attached to the right side of the ani-

spective in this study provides novel insight into the potential role of a

mal, and 125 mmHg was applied at a constant rate. The left side of each

FBR to the GranuFoam™ dressing as a possible key component to out-

animal served as the control. The animal was placed in a custom-made

comes seen in NPWT.

protective jacket (Lomir Biomedical Inc., Notre-Dame-de-l'île-Perrot,
Quebec, Canada) to protect the wounds and hold the vacuum pump. The
VAC VIA™ pump was changed out every 8 hr on each animal. The sur-

2

METHODS

|

gery was repeated again at 3, 6 and 9 days post initial surgery. The same
size GranuFoam™ piece was inserted in the wounds at each dressing

2.1

|

Animals

change and was not decreased in size even if the wound was decreasing
in size as evidenced by a change in wound perimeter. Four wounds were

Animal studies were approved by the University of Kansas Medical

excised containing GranuFoam™ at each time point by making an elliptical

Center (KUMC) Institutional Animal Care and Use Committee

cut around each wound that was approximately 1.5 cm deep and 1.5 cm

(IACUC) under animal care and use protocol (ACUP) #2016-2319.

wide with a scalpel. All excised tissue was bisected and preserved in 10%

Two female 4.2-month-old miniature Yucatan pigs weighing 30–

NBF and stored at 4 C for at least 1 week or RNAlater™ (Sigma-Aldrich)

40 kg were procured from Sinclair Bio-resources (Auxvasse, MO),

and refrigerated at 4 C for 24 hr followed by storage at

and allowed to acclimate for 14 days in an AAALAC accredited facil-

excision, tissues were sutured closed using the same procedures as

ity at KUMC. Animals were provided with food, water and social

the prior surgery. Wounds were excised from posterior to anterior over

enrichment ad libitum.

time. At each time point, open wounds were re-plugged with fresh

80 C. After

GranuFoam™. Animals were euthanized while under deep level general
anaesthesia via exsanguination. An overview of the entire experimental

2.2

|

Surgeries, sample preparation and necropsy

procedure is depicted in Figure 1A–M.

Surgeries were performed sequentially on animals, with the same animal operated on in the morning while the other animal was operated

2.3

|

Histological analysis of pig tissue explants

on in the afternoon for all procedures. Animals were placed under
general anaesthesia and ophthalmic lubricating ointment was placed

Samples preserved in 10% NBF were removed from 4 C storage

to protect the eyes. The animals were prepped with three alternating

then washed with phosphate buffered saline thrice and placed in

scrubs of betadine and alcohol. A sterile surgical drape was placed

70% ethanol for at least 24 hr. Samples were sent to the KUMC

over the animal and a hole to expose the surgical area was cut in the

histology core for paraffinization. Samples were then collected

drape. A custom biopsy punch was used with a 3D-printed acryloni-

and sent to Charles River, where samples were serial sectioned at

trile butadiene styrene stencil guide to create two rows of four full-

a thickness of 10 μm and stained with hematoxylin & eosin

5
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(H&E), Masson's Trichrome and Brown & Brenn (modified gram

respectively. Picrosirius Red staining was carried out per the man-

stain) in a repeating pattern on adjacent sections. Charles River

ufacturer's protocol. Under polarized light, collagen type I appears

followed in-house protocols for all sets of stains. H&E stains cyto-

red and collagen type III appears green. Alcian Blue staining was

plasm, matrix and plasma proteins (fibrin[ogen], fibronectin,

carried out per manufacturer's protocol, with sulphated GAGs

vitronectin)

staining blue, nuclei red and cytoplasm pink.

pink

and

cellular

nuclei

dark

purple.

Masson's

Trichrome stains matrix and plasma proteins red, collagen blue
and cellular nuclei black. Additional staining was performed inhouse utilizing Picrosirius Red (Cat# ab150681, Abcam, Cam-

2.4

|

Tissue thickness measurements

bridge, UK) staining with polarized microscopy and Alcian Blue
(Cat# 8378, ScienCell, Carlsbad, CA) staining to further character-

Unique regions of interest (ROIs) gridding was developed to

ize

account for the natural curvature and contour of wounded soft

collagen

composition

and

glycosaminoglycans

(GAGs),

F I G U R E 2 NPWT modulates thickness of skin layers. (A, B) Reconstructed H&E stained tissue sections from 200x total magnification images
with coloured, dashed lines indicating where measurements took place wherein (A) is baseline tissue control biopsy and (B) is injured tissue after
9 days of recovery. The thickness of the epidermis and dermis, for non-NPWT and NPWT, is shown in graphical form to the right. (C) Non-NPWT
was directly compared to NPWT for temporal trends over days 3, 6 and 9 for the epidermis and dermis. Grey bars indicate non-NPWT wounds.
Black bars indicate NPWT wounds. (D) Each individual day and layer were then divided into individual scatterplots to demonstrate distribution of
measurements that compared non-NPWT to NPWT. Grey circles indicate non-NPWT wounds. Black diamonds indicate NPWT wounds. Error
bars are denoted as SEM. Significance is denoted as *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, or ns for p > 0.05 and n = 4. Scale
bar = 2000 μm

6
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tissue (Figure 2A,B). For each column of ROIs in a given tissue

treatment group, for a total of up to 40 possible measurements

layer, the midpoints of the topmost ROI and the bottom most

(Figure 2).

ROI were connected, and a straight line connecting the ends of
the midpoints was measured and recorded. The thickness of the
tissue layers can vary considerably across the width of the
sample, particularly in wounded tissue, which makes single

2.5 | Histological quantification of immune cell
wound infiltration

point sampling of a given layer less than accurate. To offset this
variability,

tissue

Analysis of the immune cell infiltration into the wound site was per-

section were collected for all four wounds of each given

10

thickness

measures

per

layer

per

formed on tissue explants at days 0, 3, 6 and 9. Wounds were either

F I G U R E 3 No change in relative immune cell populations with NPWT. Tissue explanted samples at day 0, 3, 6 and 9 were stained with H&E
and analysed under light microscopy for immune cell population analysis. (A) When looking at each H&E stained slide, each wound sample was
divided into three low magnification regions indicated by the black dashed circles labelled 1, 2 and 3. Within each of the three low magnification
regions, four high-powered magnification regions were obtained based off of immune cell density. Purple cells are the epidermal cells, pink cells
are dermal cells and red quadrilateral shape is the wound. (B) A 200 H&E image displaying immune cell infiltrate containing neutrophils (1),
macrophages (2), lymphocytes (3), eosinophils (4) and fibroblasts (5). Lower panel of five high magnification images of each numbered circles from
low magnification image (above) to denote which individual cell labelled. (C) Bars graphs denoting the average acute (left) immune cell population
per ‘hpf’ and average chronic (right) immune cell population per ‘hpf’. Acute and chronic immune cell populations were identified from each of
the four high magnification (40 objective with 10 eye piece; hpf) regions from each of the three low magnification (4 objective with 10 eye
piece) regions. Grey bars indicate non-NPWT wounds. Black bars indicate NPWT wounds. The y-axis is number of cells per ‘hpf’. Error bars are
SEM. Significance is denoted as *p < 0.05, **p < 0.01, ***p < 0.001, or ****p < 0.0001 and n = 4. Scale bar = 50 μm
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treated with full wound dressings and subatmospheric pressure

manufacturer's instructions. RNA integrity was assessed using an

(i.e., NPWT) or wound dressings without subatmospheric pressure

Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA). Samples

(i.e., non-NPWT). Day 0 excisional wounds not exposed to therapy or

that displayed an RNA integrity number of 7 or greater were used for

dressings were used as a baseline for tissue comparison. A total of

downstream processing. Samples were reversed transcribed using

two wounds per experimental group were obtained from each pig giv-

High Capacity cDNA Reverse Transcription Kits (ThermoFisher Scien-

ing a total of four samples per experimental group. Samples were sec-

tific, Waltham, MA) and a qTower3 real-time thermocycler (Analytik

tioned and stained for H&E. The H&E slides were provided to a

Jena, Jena, Germany) according to manufacturer's instructions. Sam-

blinded clinical dermatopathologist, who analysed the slides for pres-

ples were analysed for purity using a QuickDrop micro-volume spec-

ence of acute and/or chronic immune cell populations via light micros-

trophotometer (Molecular Devices, San Jose, CA). Samples that

copy using an Olympus BX46 microscope, (Olympus, Center Valley,

displayed an absorbance ratio (A260/A280) of 1.8 were designated pure

PA). Histological analysis of the wounds demonstrated heterogeneity

and used for analysis. Gene expression was assessed using real-time

in their shapes, sizes and overall appearance. Therefore, in order to

quantitative polymerase chain reaction (RT-qPCR) using a qTower3

standardize the approach of cell number quantification, an array

real-time thermocycler. A Qiagen RT2 Profiler™ PCR Array for Pig

method was developed to calculate cell numbers from H&E slides at

Wound Healing (PASS-121ZC-24) was used to assess for genomic

‘easy to identify’ anchor points within the tissue. Analysis consisted

expression of 84 wound healing genes. Cycle threshold (Ct) values

of dividing the general wound structure into three regions (one region

were recorded and analysed via the Delta–Delta–Ct method. Glyceral-

at each side of the wound at the dermal-epidermal junction and

dehyde 3-phosphate dehydrogenase (GAPDH), beta-actin (ACTB),

one region at the basal surface of the wound; see Figure 3A) at low

hypoxanthine phosphoribosyltransferase-1 (HPRT1) and ribosomal

power objective (4 objective and 10 eyepiece). The three lower

protein L13a (RPL13A) were the endogenous control genes utilized by

magnification regions were then further subdivided into four higher

the array. Excision of day 0 biopsies used to inflict initial wounds were

power objective (40 objective and 10 eyepiece) regions. These

used as the baseline tissue control for which each NPWT and non-

higher magnification regions were determined by taking the most

NPWT sample Ct values were compared against to calculate the rela-

densely populated regions within 1 mm of each of the three regions.

tive change in gene expression.

The higher magnification regions were counted for both acute
immune cells (neutrophils) and chronic immune cells (lymphocytes,
macrophages and eosinophils), independently. A total of four high

2.7

|

Statistical analysis

powered fields (hpf) of view were attempted to be counted for each
of the three regions to obtain an average for up to 12 total counts per

All data are reported as means with SEM. A power analysis indicated

wound (3 regions [low mag]  4 counts [high mag] = 12 total).

that a minimum of 10 pigs were needed to perform appropriate statisti-

Wound groups were performed in duplicates for each pig (12 counts

cal tests. However, due to the nature of this study being a ‘pilot study’

 2 replicates = 24 total) and a total of two pigs were used, totalling

only two pigs were utilized. To allow for statistical tests to be performed,

for up to 48 total counts for each experimental wound group. The

wounds were performed in duplicate for each pig, providing a total of

12 total counts per wound group of each pig were added together to

four (n = 4) wounds for each treatment group. Histological analysis of

form an aggregate average of the wound site inflammation. Each of

immune cell populations and all genomic analyses were assessed using a

the averages for the NPWT treatment groups were compared to the

two-way ANOVA approach. Histological analysis of skin layer thickness

non-NPWT counterparts and indicated as total number of immune

measurements utilized a two-way ANOVA for assessing the differences

cells per ‘hpf’. This was done for both acute and chronic cells. Due to

temporally. For scatter plots of skin layer thickness for each individual

the delicacy of tissue samples during wound healing and sample

time point, an unpaired student's t-test was used.

processing with the foam in situ, some samples were torn or lost a
portion of tissue during processing and four measurement per ‘hpf’
was not always feasible.

3

2.6

3.1 |
layers

|

Gene expression and analysis

|

RE SU LT S
NPWT exposure modulates thickness of skin

When ready for processing, tissue explants were bisected with a verti-

The thickness of the epidermal and dermal layers of skin can vary

cal cut via a scalpel to split the excised wound tissue into equal halves

depending on a variety of stimuli, including hyperproliferation, inflam-

that contained the full epidermis, dermis and subcutaneous tissue

matory infiltration, edema and fibrosis. Modulation of layer thickness

layers. The GranuFoam™ was removed from each tissue sample to

for the epidermis and dermis was assessed by generating a unique

allow for maximum RNA isolation. Samples were weighed and tissues

ROI grid of the H&E-stained tissue sections (Figure 2A,B). Analysis

were trimmed outside the wound edges with a scalpel until each sam-

demonstrated that NPWT resulted in a significant increase in epider-

ple weighed 30 mg for RNA isolation. RNA was isolated and purified

mal thickness at days 3 and 6, when compared to non-NPWT

from tissue samples using a RNeasy Mini Kit (Qiagen) according to

(Figure 2C,D). Conversely, exposure of NPWT to wounds did not
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result thickening of the dermal layer, whereas non-NPWT wounds
had increased dermal thickening. This can be seen at day 9 in the non-

HODGE ET AL.

3.2 | No change in relative immune cell
populations with NPWT

NPWT wounds where there was a significant increase relative to days
3 and 6 in the non-NPWT wounds, in addition to NPWT wounds on

Analysis of the immune cell infiltration into the wound site was per-

day 9 (Figure 2C,D).

formed on both non-NPWT and NPWT wounds. The average of each

F I G U R E 4 NPWT enhances plasma protein adsorption and tissue enmeshing within GranuFoam™. Tissue samples explanted from pigs at day
3, 6 and 9 were histologically stained and analysed under light microscopy. Regions within most interior portion of GranuFoam™ were assessed
to decrease impact of ‘enmeshing’ from wound edges. (A) H&E and (B) Masson's Trichrome images at 200 magnification comparing non-NPWT
(top row) and NPWT (bottom row) over the time points of day 3 (first column), day 6 (second column) and day 9 (third column). Inset is image at
100 magnification. Protein adsorption onto GranuFoam™ denoted by arrows. Open network of pores within GranuFoam™ denoted by black ‘*’
and corresponds to ‘*’ in inset image. Residual GranuFoam™ can be seen as a ‘multi-pointed particulate’ debris residing within the wound bed.
H&E staining evaluates ECM proteins (i.e., collagen) and plasma proteins (i.e., fibrinogen) and is identified as light pink. Dark purple staining
represents cellular nuclei. Masson's Trichrome staining evaluates for collagen by staining blue. Plasma proteins and non-collagen matrix proteins
stain red. Nuclei are stained dark purple/black. It is important to note that each image represents GranuFoam™ in the wound for the same
amount of time (i.e., 3 days). Scale bar = 100 μm for 200 and 200 μm for 100 (inset)
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F I G U R E 5 NPWT limits dissemination of bacteria to adjacent tissue. Tissue samples explanted from pigs at day 0, 3, 6 and 9 were stained
with the Brown & Brenn method and analysed with high resolution imaging software and montaged together. Gram positive bacteria stain purple.
Gram negative bacteria stain pink/red. Background tissue stains light yellow. (A–F) Demonstration of bacterial invasion on day 9 of wound (B,E)
non-NPWT and (C,F) NPWT. (A–C) Low magnification images of entire wound. Solid black line #1 depicts the epidermal/dermal junction. Solid
black line #2 depicts dermal/subcutaneous junction. Light blue line #3 is an artificial addition to the image to depict furthest extent of bacterial
invasion. Dark blue line #4 is depicting GranuFoam™ (D–F) Depicts high magnification of region highlighting furthest extent of bacterial invasion.
(A,D) Day 0 excisional biopsies were used as a baseline tissue control comparison and indicated gram positive and negative bacteria. (B,E) Day
9 non-NPWT wounds. In wounds without NPWT treatment, gram negative bacteria infiltrated into the subcutaneous layer, indicated by more
diffuse and darker pink/red stain. (C,F) Day 9 NPWT wounds. In wounds treated with NPWT, the gram negative bacteria was found to be most
dense around the remaining GranuFoam™, with limited dissemination to adjacent tissue, relative to non-NPWT wounds. Day 9 (G) non-NPWT
and (H) NPWT wounds are shown to further depict bacterial localization. In the NPWT, a bacteria-laden GranuFoam™ dressing can be seen
coming out of the wound bed (denoted by black ‘#’). Scale bar = 1000 μm

of the wounds ‘hpfs’ was obtained (Figure 3C). The data demon-

wounds. Overall, no significant differences were noted between non-

strated a significant increase of both acute and chronic immune cell

NPWT- and NPWT-treated wounds for either cell population at any

populations by day 9 for both the non-NPWT- and NPWT-treated

of the time points in this study.
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F I G U R E 6 Inflammatory genomic profile of wound healing. Elliptically explanted wound tissue was assessed for expression of key genes via a
wound healing array. Significant genes involved with the inflammatory process of wound healing were grouped together and analysed at days
3, 6 and 9 post-injury, relative to baseline tissue controls. Values are reported as fold change against their respective gene expression to baseline
tissue biopsies and normalized to a group of endogenous control genes, that included GAPDH, ACTB, HPRT1 and RPL13A. Each graph compares
intragroup temporal differences and intraday difference between non-NPWT and NPWT. Non-NPWT (left set) and NPWT (right set) average fold
changes are depicting temporally with day 3 (light grey), day 6 (dark grey) and day 9 (black). A dashed line at a value of ‘1’ is used to depict average
baseline expression. Error bars are SEM and include n = 4. Significance on non-NPWT and NPWT wounds relative to the baseline tissue is
denoted with a ‘#’ above bar and indicates a p < 0.05. Intragroup and intraday significance is denoted as *p < 0.05, **p < 0.01 or ***p < 0.001
and n = 4

3.3 | NPWT enhances plasma protein adsorption
and matrix deposition within GranuFoam™

purple) within the dense protein deposits around GranuFoam™

Histological sections stained for H&E and Masson's Trichrome

H&E staining. There is an increasing deposition of matrix and plasma

particles for both non-NPWT and NPWT wounds (Figure 4A).
The Masson's Trichrome samples showed a similar trend as the

were used to analyse the interaction of the healing wound tis-

proteins (red) within the porous network of the GranuFoam™ as the

sue with GranuFoam™ in situ for each 3-day timepoint. Regions

wounds evolved over time in both non-NPWT and NPWT

towards the interior portion of GranuFoam™ were assessed for

(Figure 4B). Similarly, there was enhanced deposition of matrix and

protein adsorption upon GranuFoam™ to decrease interference

plasma proteins adsorption onto GranuFoam™ particles. Wounds

of ‘enmeshing’ from wound edges. The H&E sections demon-

exposed to NPWT had more abundant protein deposition between

strated an increasing trend in plasma protein deposits (pink)

and onto GranuFoam™ particles at every time point, relative to non-

within the porous network of the GranuFoam™ from day 3 to

NPWT (Figure 4B). As shown with the H&E sections, increased cel-

day 9 in both the non-NPWT and NPWT wounds (Figure 4A).

lular localization is seen depositing onto GranuFoam™ particles

Similarly, a thicker protein deposition can be seen adsorbing to

(Figure 4B). Additionally, enhanced tissue ingrowth (i.e., enmeshing)

the surface of GranuFoam™ particles over time for each group

from the wound bed/edges into the GranuFoam™ is seen

(Note: tissue processing can result in protein layer detaching from

(Figure S1). Both non-NPWT and NPWT wounds demonstrated an

GranuFoam™ leaving a void space). However, NPWT resulted in

increasing trend in collagen type I deposition (blue) temporally, as

more

onto

well as collagen type III (green) (Figure S2). Overall, NPWT appeared

GranuFoam™ particles at each time point (Figure 4A). Notably, the

to increase enmeshing to a greater extent in both density and pene-

H&E sections revealed enhanced immune cell localization (dark

tration depth.

abundant

protein

deposition

between

and
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F I G U R E 7 Mitogenic genomic profile of wound healing. Elliptically explanted wound tissue was assessed for expression of key genes via a
wound healing array. Significant genes involved with the mitogenic process of wound healing were grouped together and analysed at days 3, 6
and 9 post-injury, relative to baseline tissue controls. Values are reported as fold change against their respective gene expression to baseline
tissue biopsies and normalized to a group of endogenous control genes that included GAPDH, ACTB, HPRT1 and RPL13A. Each graph compares
intragroup temporal differences and intraday difference between non-NPWT and NPWT. Non-NPWT (left set) and NPWT (right set) average fold
changes are depicting temporally with day 3 (light grey), day 6 (dark grey) and day 9 (black). A dashed line at a value of ‘1’ is used to depict average
baseline expression. Error bars are SEM and include n = 4. Significance on non-NPWT and NPWT wounds relative to the baseline tissue is
denoted with a ‘#’ above bar and indicates a p < 0.05. Intragroup and intraday significance is denoted as *p < 0.05, **p < 0.01, ***p < 0.001, or
****p < 0.0001 and n = 4

Additional staining was performed to further characterize com-

(red/orange) and collagen type III (green) (Figure S2). Interestingly,

position of the deposited tissue by staining with Alcian Blue and

day 9 wounds exhibited a leading edge of GAGs at the base of the

Picrosirius Red, for characterization of sulphated GAGs and colla-

wound bed and around GranuFoam™ particles in both groups. How-

gens, respectively. Day 9 wounds further demonstrated encapsula-

ever, NPWT appeared to result in more abundant GAG deposition

tion of GranuFoam™ particles with GAGs (blue) and collagen type I

overall.
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F I G U R E 8 ECM remodelling genomic profile of wound healing. Elliptically explanted wound tissue was assessed for expression of key genes
via a wound healing array. Significant genes involved with the ECM remodelling process of wound healing were grouped together and analysed at
days 3, 6 and 9 post-injury, relative to baseline tissue controls. Values are reported as fold change against their respective gene expression to
baseline tissue biopsies and normalized to a group of endogenous control genes that included GAPDH, ACTB, HPRT1 and RPL13A. Each graph
compares intragroup temporal differences and intraday difference between non-NPWT and NPWT. Non-NPWT (left set) and NPWT (right set)
average fold changes are depicting temporally with day 3 (light grey), day 6 (dark grey) and day 9 (black). A dashed line at a value of ‘1’ is used to
depict average baseline expression. Error bars are SEM and include n = 4. Significance on non-NPWT and NPWT wounds relative to the baseline
tissue is denoted with a ‘#’ above bar and indicates a p < 0.05. Intragroup and intraday significance is denoted as *p < 0.05, **p < 0.01,
***p < 0.001 or ****p < 0.0001 and n = 4

3.4 | NPWT limits dissemination of bacteria to
adjacent tissue

resulted in a more abundant localization of bacteria within the
GranuFoam™, with less dissemination into adjacent tissue regions
(Figure 5C,F,H). Notably, an image of a NPWT treated wound at day

Tissue sections were further analysed for bacterial localization via a

9 demonstrating a dense bacteria-laden dressing detaching from the

modified Gram stain (Brown & Brenn) to assess bacterial presence.

wound bed can be seen in Figure 5H.

Gram negative bacteria are stained pink/red, and gram positive bacteria are stained deep purple. There is limited gram positive bacteria at
the superficial surface of the skin making up the skin flora but with

3.5

|

Genomic wound healing profile

minimal gram positive bacteria present as a whole (Figure 5A–H).
Conversely, there is a more abundant source of gram negative bacte-

Tissue isolated from each wound was assessed for changes in expres-

ria found within the wound and adjacent tissue locations within the

sion of wound healing genes via a wound healing array. Expressional

dermis and subcutaneous regions. Overall, gram negative bacterial

changes were first compared to baseline tissue controls (denoted as

burden is more diffusely spread in the non-NPWT wounds, infiltrating

‘#’ if significant) and then compared temporally for intragroup differ-

to a greater extent away from the wound bed/edge into the dermis

ences (i.e., NPWT day 3 vs. NPWT day 9), in addition to comparing

and subcutaneous regions (Figure 5B,E,G). Wounds exposed to NPWT

intraday differences between groups for each time point (i.e., NPWT
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F I G U R E 9 GranuFoam™ induces FBR. Tissue samples explanted from pigs at day 9 were histologically stained and analysed under light
microscopy. Regions within/around wound bed were assessed. Characterizing (A) non-NPWT and (B) NPWT at day 9 with H&E (left column) and
Masson's Trichrome (middle column) images at 100 (top rows) and 200 (bottom row) magnification for presence of a FBR. A 400 magnification
image of giant cells (white arrows) upon GranuFoam™ within the wound are also shown (large rightmost panels). H&E images demonstrate waves
of fibrous matrix material (pink) and dense chronic immune cell deposits around GranuFoam™. Masson's Trichrome images demonstrates similarly,
waves of dense fibrous material of different matrix components including collagen (blue) and other matrix-derived components (red)
encapsulating the GranuFoam™. Scale bar = 50 μm for 400, 100 μm for 200 and 200 μm for 100

day 9 vs. non-NPWT day 9). Expressional changes in key genes

significantly increased on day 9 for NPWT, relative to all intragroup

involved in inflammation are shown in Figure 6, which demonstrated

and intraday comparisons.

similar responses in non-NPWT and NPWT wounds when comparing

Another important stimulus for wound healing is mitogenic signal-

to basal tissue, including both intraday comparisons and temporal

ling, which includes a variety of growth factors and other proliferative

trends within groups. Both non-NPWT and NPWT exhibited a signifi-

markers. The mitogenic expressional profile is shown in Figure 7.

cant decrease from basal tissue for CSF3 (also known as G-CSF) on

Again, globally there is similar response patterns in non-NPWT and

days 3 and 9 but not day 6. Significant differences between non-

NPWT compared to basal tissue. When comparing both non-NPWT

NPWT and NPWT are seen in IL10, CSF2 (also known as GM-CSF)

and NPWT wounds to basal tissue, there is a significant decrease in

and CD40L. IL10 is significantly increased from basal tissue expres-

FGF2 and ANGPT1, whereas there is a significant increase in FGF7,

sion in non-NPWT, whereas NPWT does not result in a significant

WISP1, TGFβ3 and CTNNB1. Notably, there is an increase in TGFβ1

increase. CSF2 demonstrated a significant increase at day 9 for NPWT

and IGF1 only for non-NPWT, compared to basal tissue, but not

compared to non-NPWT on day 9. Similarly, expression of CD40L is

NPWT wounds. Both non-NPWT and NPWT had a significant
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intragroup increase of ANGPT1 on day 6, though only NPWT

demonstrated that the VAC is able to augment local blood flow,

sustained that increase on day 9. Similarly, there is an increase of

reduce edema and remove exudative fluids within the wound

CTNNB1 on day 6 compared to day 3 for both non-NPWT and

site.25,44,45 The VAC is thought to enhance blood flow by promoting

NPWT. The only genes to show significant intraday differences

fluid egress from the wound and decreasing interstitial pressure on

between non-NPWT and NPWT were WISP1 and IGF1. WISP1

the microvasculature, resulting in a decrease in capillary afterload

showed an increase on day 6 for non-NPWT, whereas on day 9 WISP1

within the tissue.45,46 The VAC has also been shown to enhance the

was higher in NPWT. IGF1 had a significantly higher expression on

rate of granulation tissue deposition, which is considered to play a sig-

day 3 in non-NPWT when compared to NPWT.

nificant role in wound healing outcomes seen with the VAC system

Lastly, expressional changes in extracellular matrix (ECM)

due to matrix deposition and the highly vascular nature of granulation

remodelling genes were assessed and are shown in Figure 8. Expres-

tissue.25,26 One suggested mechanism for the increased rate of granu-

sional patterns for different collagens were similar between both non-

lation tissue deposition is thought to be due to mechanotransduction

NPWT and NPWT, compared to basal tissue. There was a significant

signalling, which results when an external force leads to structural

increase temporally from day 3 to day 9 in both non-NPWT and

interactions

NPWT for COL1A2 and COL5A2, in addition to a significant increase

Mechanotransductive signalling then results in enhanced mitotic

in COL3A1 for NPWT only. Notably, there was a significant increase

activity and global protein production.46–48 Additionally, enhanced

in expression of multiple proteases on day 9 for NPWT relative to

neovascularization within granulation tissue is thought to result in

both basal tissue and non-NPWT wounds, including MMP-1, MMP-3

greater perfusion to the tissue, with subsequent increases in neutro-

and MMP-9. Whereas a decrease in TNC is seen in NPWT compared

philic response and antibacterial activity with the VAC25

between

the

ECM

and

cytoskeleton.47

cellular

to non-NPWT for every time point. Interestingly, expression of

Overall, the VAC system is well known for its ability to modulate

COL1A2, COL3A1 and MMP-3 are all significantly increased when

wound healing and its clinical outcomes are well-documented.42,49–51

comparing the day 0 wounds to the day 0 baseline tissue biopsies

However, studies are yet to clearly demonstrate mechanistically how

(Figure S3), elucidating to the early signalling (within 60 min of

the VAC system modulates wound healing at a genomic and proteo-

wounding) responses potentially important for later downstream sig-

mic level that correlates to what is seen clinically. Specifically, how

nalling responses seen.

exposure to subatmospheric pressure augments tissue deposition,
inflammation and the overall wound healing process. To our knowledge, no study to date has looked at an in situ perspective with VAC

3.6

|

GranuFoam™ induces FBR

therapy or utilized a GranuFoam™ dressed wound without subatmospheric pressure to assess the wound healing response in the pres-

The in situ viewpoint paired with use of GranuFoam™ dressed

ence of the GranuFoam™ dressing alone. Moreover, the effect of

wounds without subatmospheric pressure exposure (non-NPWT) pro-

wound

reinjury

via

repetitive

removal

and

reapplication

of

vided a novel perspective to visualize the presence of a FBR to the

GranuFoam™ to wounds should be clarified. Thus, elucidation to the

GranuFoam™ dressing material within wounds. This is shown histo-

dynamic

logically with the H&E and Masson's Trichrome stained sections

enhanced granulation tissue deposition and bacterial mitigation with

(Figure 9A,B). The GranuFoam™ particles are seen encapsulated by

the VAC, remains in question.

mechanism(s)

of

wound

environment

augmentation,

dense chronic immune cell populations including macrophages/histio-

In this study, augmentation of the immune response was assessed

cytes, eosinophils and lymphocytes. These cells are intermixed with

histologically by quantifying acute (neutrophils) and chronic (lympho-

fibroblasts and accompanied by deposits of fibrous matrix (H&E—pink,

cytes, macrophages and eosinophils) immune cell populations within

Trichrome—blue/purple/red) around the GranuFoam™. This response

the GranuFoam™ and surrounding tissue in situ. A temporal increase

is seen in both non-NPWT and NPWT (Figure 9A,B). Additionally, to

was observed in both acute and chronic cell populations, though no

further support the presence of a FBR, there is formation of giant cells

differences were noted overall between non-NPWT and NPWT. This

(arrows) in non-NPWT and NPWT wounds, both within the wound

data is contrary to previously suggested antimicrobial effects of

and within the wound bed, accompanied by neovascularization

NPWT. Indicating that the increases in neutrophil response in previ-

(Figure S10).

ous studies is potentially not a direct result of NPWT. Instead, the
equivalent immune cell response seen is more likely a result of a stimulus that is consistent between the non-NPWT and NPWT groups.

4

|

DISCUSSION

One such consistent event occurring in both non-NPWT and
NPWT wounds is the repetitive insertion of GranuFoam™ and dress-

In this study, new insight was provided for wound healing in the con-

ing changes that occurred every 3 days. The repetitive removal of the

text of NPWT utilizing the wound VAC system. The VAC system was

GranuFoam™ likely induces a mechanical insult to the healing tissue

a landmark development in the field of wound healing and has pro-

due to enmeshing. In this study, we demonstrate matrix deposition

vided clinicians the ability to accelerate the wound closure process in

within the GranuFoam™ dressing, including collagens type I and type

a variety of applications.26,31 The VAC has proven advantageous in

III for both non-NPWT and NPWT wounds (Figures S1 and S2). Con-

difficult to treat and non-healing wounds.42,43 Previous studies have

sequently, upon removing the GranuFoam™, not only is the dressing
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removed but tissue enmeshing leads to subsequent removal of fresh

wound bed to a new ‘baseline’ after each dressing change. Reinjury

tissue within the wound bed, reinjuring the wound. Notably, NPWT

and reinsertion of a new GranuFoam™ dressing that has not yet been

did appear to increase the relative abundance of matrix deposition

coated/encapsulated by proteins and cells results in a new stimulus

and plasma protein adsorption around and upon the GranuFoam™,

and a more robust response from a new ‘baseline’ from the primed

providing a substrate for bacterial colonization. It was due to this phe-

tissue. Our results show that although the overall immune cell

nomenon that led to our hypothesis that bacterial mitigation when

response is similar in non-NPWT and NPWT, there may be concentra-

utilizing the VAC may be occurring via an alternative mechanism than

tion of cells, protein and enmeshing within the GranuFoam ™ dressing

originally thought.

with NPWT.

The level of bacterial burden and the composition of bacteria are

Futhermore, one of the main reasons the VAC system is used

both important aspects when discussing a wound healing environ-

clinically is because it is thought to expedite the evolution of the

ment. Previous studies suggest that the wound VAC decreases overall

wound healing process by enhancement of granulation tissue and

bacterial burden via enhanced perfusion to the tissue and a subse-

ECM deposition, promotion of wound contraction and subsequent

quent increase in neutrophilic response.25 By performing in situ analy-

decreases in the size of the wound site.25,49 This may suggest that

sis of the GranuFoam™ dressed wounds, localization of bacterial

NPWT is able to stimulate ECM production and remodelling at a

colonies within the open-cell meshwork of the GranuFoam™ and the

greater capacity than wounds not treated with NPWT. Yet, the geno-

surrounding tissue were visualized. This perspective allowed for the

mic data in this pilot study suggest that wounds treated with NPWT

entire wound to be visualized and extent of bacterial dissemination to

tend to have equivalent expressional levels of different collagens rela-

be directly compared between treatment groups; whereas previous

tive to non-NPWT wounds, including COL1A1, COL1A2, COL3A1,

studies have assessed bacterial burden via ex vivo analysis of wound

COL4A3 and COL5A2. Additionally, there was no significant differ-

biopsies, which does not allow for direct visualization of bacterial

ence in ACTA2 expression after NPWT (Figure S4), compared to non-

dissemination to adjacent tissue, nor does it take into account the role

NPWT, indicating that wound contraction via transition of fibroblasts

of the dressing material on bacterial burden. The enhanced protein

to myofibroblasts was insignificant. However, there was a significant

deposition seen in NPWT was associated with higher abundance of

increase in MMP expression after NPWT, relative to non-NPWT. On

bacterial localization within the GranuFoam™ dressing instead of the

day 9, increases in MMP1, MMP3 and MMP9 can be seen. The mech-

surrounding wound tissue. Therefore, the visualization of the bacterial-

anism behind this is not fully understood but MMPs such as MMP9

laden GranuFoam™ might explain, in part, the apparent antibacterial

are intimately involved in inflammation, remodelling and epithelializa-

properties of the VAC system, but only upon removal of the enmeshed

tion activity. Additionally, MMP9 is involved in the FBR in an attempt

dressing. Without removal, the bacterial-laden GranuFoam™ may not

to expel foreign objects. FBGC formation tends to occur in the range

suppress the bacterial burden to a clinically significant level and could

of 7–14 days post-exposure; therefore, the genomic changes occur-

lead to a localized infection as well as a systemic response and septice-

ring in day 9 samples could provide insight into this transition.24 Addi-

mia in a patient. This is clinically significant because bacteria can induce

tionally, sulphated GAGs are known modulators of wound healing via

chronic inflammation within a wound and locally increase ROS and

regulation of protease activity, including MMPs, and are seen

proinflammatory cytokines. Therefore, the mechanism of bacterial miti-

increased with NPWT at day 9 (Figure S2).52,53

gation by the VAC system is of fundamental importance.

Additionally, no differences were seen in expression of STAT3 or

There is an increase over time in neutrophils into the wound area

AKT, which are pleiotropic proteins involved in a number of prolifera-

with NPWT. However, this increase is seen in non-NPWT wounds as

tive and bioactive pathways in wound healing, though significant

well, which is contrary to what previous studies have postulated as a

changes in WISP1 expression in both non-NPWT and NPWT were

possible mechanism for bacterial mitigation.25,26,34 One potential

seen. WISP1 is a secreted product of the Wnt/β-Catenin family of

explanation for the steady increase in immune cells over time is

proteins and has a role in proliferation and tissue regeneration but can

potentially, in part, due to the repetitive irritation from dressing

also be involved in fibrotic healing.54 The decrease in CTNNB1

changes. Another possible explanation is that the GranuFoam™ dress-

(β-catenin) suggests that WISP1 may be induced independent of

ing itself is inducing a FBR.24 The presence of giant cells with fibrotic

β-Catenin. Similarly, there was a significant decrease in FGF2 and

and immune cell encapsulation of GranuFoam™ particles provides

ANGPT1 expression and an apparent decrease in VEGFA, which are

new insight that a FBR to the GranuFoam™ dressing may in fact have

key angiogenic factors. Similar results were seen in the KCI study

a role in outcomes seen with VAC therapy.

with the VAC by Derrick et al.55 Conversely, our histological data

The in situ histology perspective in this study was able to reveal

demonstrates evidence of intense granulation tissue formation and

the increasing trend of protein and immune cell presence in and

neovascularization in both non-NPWT and NPWT (Figure S10).

around the GranuFoam™ dressing in both non-NPWT and NPWT

Therefore, the neovascularization pathway of NPWT warrants further

wounds. Notably, each processed wound time point is equivalent and

investigation with variable time points and stratified analysis of loca-

is the result of 3 days within the wound, and theoretically should have

tions within the wound.

similar deposits of protein and immune cell populations. However, it

FGF7 (also known as keratinocyte growth factor) was significantly

appears there is an enhanced response at each sequential time point,

increased in non-NWPT wounds for all time points, relative to basal

with the GranuFoam™ dressing and dressing changes priming the

tissue. This was only seen in day 9 NPWT wounds. This suggests a
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potential role of VAC therapy in modulating keratinocyte activity.

GranuFoam™ may prompt alternative activation of macrophages and

A similar trend in IGF1 expression is seen, with non-NPWT increased

subsequent giant cell formation via an eosinophil-dependent pathway.

compared to basal tissue, but not NPWT. IGF1 is an important growth

The insights provided by this study offer a new understanding into

factor involved in multiple wound healing pathways, including prolifer-

the fundamental workings of how the VAC system exerts its effects on

ation and migration of fibroblast and keratinocytes.56 Notably, TNC

wound healing. However, more studies are needed to further refine

has a significant drop in expression in NPWT, relative to non-NPWT.

and validate these novel perspectives since this study was only a

TNC is involved in cellular migration and differentiation, including for

‘proof of concept’ that utilized two animals. Larger studies with more

macrophages and keratinocytes.57 Combining the decreased expres-

animals and further genomic and proteomic analyses will help provide

sion of FGF7, IGF1 and TNC, we see that NPWT may potentially be

insight into the results seen in this study. Interestingly, a recently publi-

negatively regulating keratinocyte activity.

shed study investigating NPWT in a porcine wound model as well

Interestingly, for the level of inflammation seen histologically, the

briefly mentions the observation of wound filler-associated foreign

relative expression of pro-inflammatory cytokines did not appear to

body reaction to residual dressing material left within the wounds,61

be significantly altered, including expression of IL1B, IL6ST, TNF and

further supporting the FBR findings in this study.

IFNG. Some genes that exhibited significant changes were IL10,

The main limitation in this study, as mentioned above, is the lim-

CSF2, CSF3 and CD40L. IL10 is an important anti-inflammatory cyto-

ited number of subjects due to the purpose of the study being a

kine and plays a pivotal role in alternative macrophage activation and

‘proof of concept’. To improve the rigour of the data acquired, multi-

polarization from an M1 to M2 phenotype. M2 macrophages are

ple experimental techniques were used to provide a variety of per-

involved in tissue remodelling, granulation tissue formation, fibrosis

spectives including the in situ analysis of GranuFoam™, which has not

58

and giant cell formation.

Additionally, the day 9 surge in CD40L

been previously published to our knowledge. Moreover, the majority

could be due to involvement of a number of different pathways. One

of prior studies on VAC-associated wound healing models have used

of which is that CD40L is involved in angiogenic signalling via stimu-

standard gauze dressings as a control. To our knowledge, none have

lating MMP9 release of endothelial progenitor cells.59 The CD40L/

used the GranuFoam™ dressing without subatmospheric pressure as a

MMP9/EPC axis could explain the lack of prototypical angiogenic sig-

control comparison. By using this treatment control, the effect of sub-

nalling discussed earlier. Therefore, further investigation into the role

atmospheric exposure on wounds was isolated. An additional limita-

of this signalling axis with NPWT is warranted.

tion is that the immune cell analysis for this study was performed via

Since its inception in 1997, the VAC has been shown time and

histological evaluation with H&E. Although this methodology is com-

time again to augment the wound healing response by enhancing

monly used and accepted for histological immune cell analysis, further

ECM and granulation tissue deposition, promoting neovascularization

characterization of specific immune cell populations and their localiza-

and increasing the neutrophilic response to combat bacteria. These

tion with the wound bed via immunolabelling could provide beneficial

responses are claimed to be a result of exposure to subatmospheric

information and should be investigated in future studies. Future stud-

pressure (i.e., NPWT), as previously discussed. VAC therapy in this

ies investigating other genomic markers, and the location within

study demonstrated similar outcomes. However, the lack of increase

wounds of specific cells expressing these markers, would also help

in expression of collagens, angiogenic markers and immune cells with

generate a more well-rounded scientific understanding. Similarly, per-

exposure to NPWT relative to non-NPWT suggests that these prior

forming studies that assess early (0–12 hr) and late (>9 days) signalling

mechanistic hypotheses about NPWT may not be the entire story.

markers could provide valuable insight into the physiological mecha-

Our impression is that application of the GranuFoam™ dressing to

nisms of VAC therapy and the FBR.

wounds induces a FBR, ultimately resulting in a chronic inflammatory

In summary, there remains much to be learned about NPWT and

stimulus with fibrotic and immune cell encapsulation of the

the potential role the dressing material plays in wound outcomes. Fur-

GranuFoam™ dressing. The FBR results in enhanced granulation tissue

ther insight into the interaction between cells, ECM, bacteria and the

formation, neovascularization and immune cell infiltration of tissue.

wound dressing could provide understanding into the complex repara-

Whether exposure to NPWT augments the FBR relative to non-

tive processes of wound healing. The mechanical properties of NPWT

NPWT is yet to be determined and warrants further investigations.

have been postulated to improve overall wound healing. Though the

However, NPWT did appear to increase matrix deposition, protein

role of irritation due to interval reapplication of the dressing is not ade-

adsorption and subsequent bacterial and immune cell localization

quately understood nor is the role of the tissue ‘priming’ that was

within the GranuFoam™, preventing a more dispersed infection and

demonstrated in this study. Nonetheless, dressing removal is clinically

resulting in a more ‘tightened’ wound morphology. Upon additional

necessary to ensure proper healing and avoidance of dressing integra-

histological analysis, both non-NPWT and NPWT wounds revealed a

tion into a healed wound. This study demonstrates that bacteria are

mixed chronic inflammatory infiltrate with abundant eosinophils local-

residing within the enmeshed GranuFoam™ dressing and that the

ized in tissue adjacent to GranuFoam™ (Figure S10). This is the first

encroachment of tissue into the dressing likely provides an advanta-

demonstration of the potential role of eosinophils in modulating the

geous environment for bacterial growth. Our impression is that NPWT

inflammatory response with VAC therapy. The presence of a foreign

enhances tissue enmeshing into GranuFoam™, and without intermit-

body potentially results in Th2 activation of eosinophils which are

tent removal higher bacterial loads may be seen. Lastly, this study

known to be involved in M2 polarization of macrophages.60 Thus,

reveals the potential role of a FBR to GranuFoam™ as a potential
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fundamental component to outcomes seen with NPWT. Insight into
cell recruitment and genomic profiling for the different stages of
wound healing could provide improved understanding of important signals that prompt the subsequent cascading series of events seen later.
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